AUDIT MicroControls, Inc. Announces New Linearity FLQ TDM for Roche Systems

                                                                                                                                            AUDIT MicroControls, Inc. is pleased to announce the following new addition to our line of calibration verification/linearity and daily quality control products: Linearity FLQ TDM for Roche Systems. This product is intended to simulate human patient serum samples for the purpose of determining linearity, calibration verification, and verification of reportable range for Acetominophen, Amikacin, Carbamezepine, Digoxin, Gentamicin, NAPA, Phenobarbital, Phenytoin, Procainamide, Quinidine, Salicylate, Theophylline, Tobramycin, Valproic Acid and Vancomycin. 

AUDIT MicroControls, Inc. Announces New CalVer Drugs of Abuse for Roche Systems

                                                                                                                                                                       AUDIT MicroControls, Inc. is pleased to announce the following new additions to our line of calibration verification/linearity and daily quality control products: CalVer FLQ Drugs of Abuse for Roche Systems. This product is a ready-to-use liquid product, consisting of four levels that demonstrate a linear relationship to each other when assayed for 6-AM, AMPH, BARB, BENZ, BUP, COCA, METH, OPIA, OXY, PCP, and THC. With an open vial stability of 3 days when stored at 2-8°C.

A Message to Our Customers

To start, we would like to thank you, our customers, for your dedication and relentless effort to serve amid the COVID-19 pandemic. You truly are the unsung heroes in these challenging times.